SWE
Toggle navigation
English
Svenska
About Us
The Company
Board & Management
Scientific Advisory Board
Scientific Publications
Events & Mediawatch
Careers
Contact Us
Expanded Access Policy
Diabetes
Products
Manufacturing
Clinical Trials
Investors
Investor Relations
CEO Comments
Corporate Governance
Press Releases
Financial Reports
Financial Calendar
Rights Issue
Skip Navigation Links
Home
»
The Company
»
Scientific Publications
Scientific publications on subjects and technologies related to Diamyd Medicals research and activities.
The burden of Diabetes
IDF Diabetes Atlas
Modeling the Total Economic Value of Novel Type 1 Diabetes (T1D) Therapeutic Concepts
JDRF T1D Fund, Health Advances
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
Diabetes Technol Ther. 2019 Feb;21(2):66-72
Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study
Lancet. 2018 Aug 11;392(10146):477-486
Novel subgroups of adult-onset diabetes and their association
Lancet Diabetes Endocrinol. 2018 May;6(5):361-369
Economic Costs of Diabetes in the U.S. in 2017
Diabetes Care. 2018 May;41(5):917-928
Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial
Diabetes. 2014 Feb;63(2):739-48
Type 1 diabetes
Lancet. 2014 Jan 4;383(9911):69-82
Immunotherapy with Diamyd
®
(GAD65)
Intralymphatic GAD-Alum (Diamyd
®
) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2
J Clin Endocrinol Metab. 2022 Aug 18;107(9):2644-2651.
Association between treatment effect on C-peptide preservation and HbA1c in meta-analysis of glutamic acid decarboxylase (GAD)-alum immunotherapy in recent-onset type 1 diabetes
Diabetes Obes Metab. 2022 Aug;24(8):1647-1655.
Antigen-based Immunotherapy Improves Glycemic Metrics and β-Cell Function
J Clin Endocrinol Metab. 2022 Jul 26;dgac437.
Long-Term GAD-alum Treatment Effect on Different T-Cell Subpopulations in Healthy Children Positive for Multiple Beta Cell Autoantibodies
J Immunol Res. 2022 May 25;2022:3532685.
Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial
Diabetes Care. 2021 Jul;44(7):1604-1612.
Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes
Diabetologia volume 63, pages2177–2181(2020)
Intralymphatic Glutamic Acid Decarboxylase-Alum Administration Induced Th2-Like-Specific Immunomodulation in Responder Patients: A Pilot Clinical Trial in Type 1 Diabetes
J Diabetes Res. 2018 May 24;2018:9391845
More on Intralymphatic Injection of Autoantigen in Type 1 Diabetes
N Engl J Med. 2017 Jul 27;377(4):403
Intralymphatic Injection of Autoantigen in Type 1 Diabetes
N Engl J Med. 2017 Feb 16;376(7):697-699
GAD vaccine reduces insulin loss in recently diagnosed type 1 diabetes: findings from a Bayesian meta-analysis
Diabetologia. 2017 Jan;60(1):43-49
Beta cell regeneration with Remygen
®
(GABA)
A Clinically Applicable Positive Allosteric Modulator of GABA Receptors Promotes Human β-Cell Replication and Survival as well as GABA’s Ability to Inhibit Inflammatory T Cells
Journal of Diabetes Research. 2019; 2019:5783545
Clinically applicable GABA receptor positive allosteric modulators promote ß-cell replication
Sci Rep. 2017 Mar 23;7(1):374
Long-Term GABA Administration Induces Alpha Cell-Mediated Beta-like Cell Neogenesis
Cell. 2017 Jan 12;168(1-2):73-85
Study of GABA in Healthy Volunteers: Pharmacokinetics and Pharmacodynamics
Front Pharmacol. 2015 Nov 10;6:260
Oral Treatment with c-Aminobutyric Acid Improves Glucose Tolerance and Insulin Sensitivity by Inhibiting Inflammation in High Fat Diet-Fed Mice
PLoS One. 2011;6(9):e25338
Order GAD for preclinical research
ORDER
©
Privacy Policy
|
Cookie Policy
|
Expanded Access Policy
Share This Page
select
Facebook
Twitter
LinkedIn
Google Plus
Pinterest
Tumblr
StumbleUpon
Blogger
MySpace
Digg
Reddit
Email
GAD PRODUCTS
Order GAD for preclinical research